Institute of Dentistry
- Tumor-associated CD3- and CD8-positive immune cells in colorectal cancer: The additional prognostic value of CD8+-to-CD3+ ratio remains debatable (2022)
- Tumor-Associated Trypsin Inhibitor (TATI) as a Biomarker of Poor Prognosis in Oropharyngeal Squamous Cell Carcinoma Irrespective of HPV Status (2021)
- Tumor Microenvironment-Based Risk Stratification of Oropharyngeal Squamous Cell Carcinoma (2025)
- Tumor-stroma ratio is a promising prognostic classifier in oropharyngeal cancer (2023)
- Tumour-infiltrating lymphocytes in oropharyngeal cancer: a validation study according to the criteria of the International Immuno-Oncology Biomarker Working Group (2022)





